Cardiovascular disease: identifying and supporting people most at risk of dying early
KEYWORDS: health, evidence, services, disadvantaged, people, interventions, smoking, studies, study, risk, cessation, local, review, effectiveness, smoking cessation

concluded that increased risk of CHD associated with SMI and antipsychotic medications requires flexible solutions with clear lines of responsibility for assessing, communicating and managing CHD risks. Evidence Statement 14ST There is a paucity of good quality research on the effectiveness of pharmacist interventions to improve compliance with lipid-lowering therapy, particularly in disadvantaged individuals. Results from the 4 studies identified (2 RCTs [-, -] 1 UCBA [uncontrolled before and after study] [-] and 1 observational study [-]) should be viewed with caution owing to poor methodological quality and doubts about applicability to disadvantaged individuals. Evidence Statement 15ST Evidence from 1 low-quality RCT (-) suggests that telephone reminders and postcards to reinforce messages about coronary risk reduction does not produce significant improvements in short-term compliance in patients prescribed pravastatin treatment. Results should be viewed with caution as the poor-quality study is likely to be highly biased and may not be applicable to disadvantaged individuals. Evidence Statement 16ST Well-conducted research examining patient education to improve compliance with lipid- lowering therapy is required before firm conclusions can be made regarding its effectiveness, particularly in disadvantaged individuals. Evidence from 1 uncontrolled before-and-after study (+) of nurse-led education in heart failure patients suggested there was
